Mobile-Based Contingency Management to Promote Daily Self-monitoring in Primary Care Patients
CompletedNot applicableNCT03962491
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This project examines the efficacy and feasibility of contingency management (CM), delivered using a novel, fully automated CM app (DynamiCare Rewards), to promote daily self-monitoring of pain symptom severity and related variables (e.g., mood, sleep), as well as Rx opioid, alcohol, marijuana, cannabidiol (CBD), and Rx benzodiazepine use in a sample of chronic pain patients. The project will conduct a 2-arm randomized clinical trial (RCT) comparing those receiving reinforcement escalating with continuous performance of the target behavior (CM group) vs those asked to complete the survey but will not be incentivized (C group).
Study details
- Official title
- Using Mobile-based Contingency Management to Promote Daily Self-monitoring of Pain Severity and Prescription Opioid Use in a Primary Care Sample of Chronic Pain Patients
- Conditions
- Interventions
- Behavioral: Daily Self-Monitoring Surveys + Contingency Management
- Behavioral: Daily Self-Monitoring Surveys
- Sponsor
- Virginia Commonwealth University
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Start date
- 2020-01-24
- Primary completion
- 2021-04-14
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. at least 18 years of age; 2. own a study-compatible smartphone (iPhone or Android device); 3. report non-cancer related chronic pain (consistent daily pain) for 3 months or greater; 4. able to provide informed consent for study participation; 5. used prescription opioids in the past 30 days; and 6. having ever been prescribed 1 or more opioid medication(s) for pain management. Exclusion Criteria: 1. currently pregnant; 2. presenting with language barriers, cognitive impairment, or serious medical or psychiatric illness that in the opinion of the Investigator would preclude them from providing informed consent or participating in the study; and 3. visual impairment or motor impairment that would interfere with use of a smartphone.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03962491